Acquiring Company
Battery Ventures
Acquired Company
Enzo Life Sciences
Description
Battery Ventures has successfully completed its acquisition of Enzo Biochem, a leader in life-science research reagents. This move aims to accelerate Enzo’s growth and innovation by leveraging Battery's investment expertise. Jason Apter has joined Enzo as CEO to further enhance the company's capabilities and expansion into new markets. The acquisition is expected to strengthen Enzo's position in the research-reagents market.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed